COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases

Sorin Draghici; Tuan-Minh Nguyen; Larry A. Sonna; Cordelia Ziraldo; Radu Vanciu; Raef Fadel; Austin Morrison; Mayur Ramesh; Gil Mor

doi:10.1101/2020.05.06.20076687

Data Availability

The gene expression data analyzed here are available in GEO as data set GSE147507. All clinical data will be publicly available one year after the peer-review publication date.

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

Community Reviews

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases

Data Availability

Subject Area

Citation Manager Formats

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases

Data Availability

Subject Area

Follow this preprint